Laman UtamaABCL • NASDAQ
add
AbCellera Biologics Inc
$3.61
Selepas Waktu Dagangan:(2.50%)+0.090
$3.70
Tutup: 27 Feb, 8:00:00 PTG GMT-5 · USD · NASDAQ · Penafian
Tutup sebelumnya
$3.59
Julat hari
$3.36 - $3.62
Julat tahun
$1.89 - $6.52
Permodalan pasaran
1.09B USD
Bilangan Purata
4.47J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Hasil | 44.85J | 788.18% |
Perbelanjaan pengendalian | 23.34J | 8,713.28% |
Pendapatan bersih | -8.94J | 73.85% |
Margin untung bersih | -19.94 | 97.06% |
Pendapatan bagi setiap syer | -0.03 | 75.00% |
EBITDA | -22.46J | 13.76% |
Kadar cukai berkesan | 54.13% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 533.83J | -14.67% |
Jumlah aset | 1.36B | -0.26% |
Jumlah liabiliti | 390.05J | 28.11% |
Jumlah ekuiti | 966.90J | — |
Syer tertunggak | 303.16J | — |
Harga kepada buku | 1.11 | — |
Pulangan pada aset | -5.27% | — |
Pulangan pada modal | -6.45% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -8.94J | 73.85% |
Tunai daripada operasi | -34.74J | -334.29% |
Tunai daripada pelaburan | 75.14J | 110.45% |
Tunai daripada pembiayaan | 4.12J | -0.65% |
Perubahan bersih dalam tunai | 44.80J | 50.92% |
Aliran tunai bebas | -6.97J | 90.38% |
Perihal
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
CEO
Diasaskan
2012
Ibu pejabat
Tapak web
Pekerja
562
